Here’s why Jim Cramer is warning investors to stay away from ScottsMiracle-Gro

Here’s why Jim Cramer is warning investors to stay away from ScottsMiracle-Gro


CNBC’s Jim Cramer on Thursday told investors to resist the urge to add ScottsMiracle-Gro to their portfolios, despite the stock’s low valuation.

“Historically, this is a great time of year for anything garden related because it’s planting season, and Scotts is a name that we used to get a ton of questions about. … But, over the past thirteen months, these shares have been obliterated,” the “Mad Money” host said.

“While ScottsMiracle-Gro might seem cheap on a price to earnings basis, the problem is that the earnings forecast keeps coming down … and management doesn’t have a handle on how bad it’s going to get,” he later added.

ScottsMiracle-Gro stock fell 6% on Thursday. The company reported better-than-expected earnings in its previous quarter two days before.

JPMorgan upgraded ScottsMiracle-Gro to overweight from neutral on Wednesday, pointing to the stock’s valuation, high margins and market leadership. Stifel downgraded the stock from overweight to hold.

Cramer said that he agrees with Stifel’s more bearish stance on Scotts, particularly because of the company’s struggles with rising raw costs, lack of confidence regarding an earnings target of $8 a share and his concerns with the performance of Scotts’ Hawthorne division. Hawthorne operates in cannabis, an industry Cramer says has been beaten down for the last year.

“On top of that, Scotts has an ugly enough balance sheet that they don’t see management embracing an aggressive buyback, either. In short, business is bad and there’s not much Scotts can do to make it better,” Cramer said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More